Catalyst Wire Dossier Catalyst Wire Dossier

Tirzepatide

tirzepatide
Drug timelines are a Plus or Pro feature.

122 regulatory and trial events tracked for Tirzepatide, covering 2019-08-20 to 2026-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both [Phase 3]

See pricing